Literature DB >> 2106697

Updated forecasts of the costs of medical care for persons with AIDS, 1989-93.

F J Hellinger1.   

Abstract

Data on the number of AIDS cases reported to the Centers for Disease Control (CDC) from January 1984 to June 1989 are used to predict the number of AIDS cases that will be diagnosed during the years 1989 through 1993. Using quadratic and linear models with the most recent data, it is projected that about 44,000 cases will be diagnosed in 1989, 56,000 in 1990, 70,000 in 1991, 87,000 in 1992, and 104,000 in 1993. These projections are lower than estimates derived using data from January 1984 to June 1988, and they are similar to estimates derived by the CDC. The lifetime medical care cost of treating a person with AIDS is estimated to be about $75,000 (all estimates are in 1988 dollars) assuming that the average length of survival is 15 months and that the intensity of care (that is, the cost of medical care per month) does not fall as longevity rises. This total, $75,000, reflects recent increases in the length of survival and the diffusion of costly drug therapies (for example, AZT and aerosol pentamidine). This study forecasts that the cumulative lifetime medical care costs of treating all people diagnosed with AIDS during a given year to be about $3.3 billion in 1989, $4.3 billion in 1990, $5.3 billion in 1991, $6.5 billion in 1992, and $7.8 billion in 1993.

Entities:  

Mesh:

Year:  1990        PMID: 2106697      PMCID: PMC1579985     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  9 in total

1.  Estimates of the direct and indirect costs of acquired immunodeficiency syndrome in the United States, 1985, 1986, and 1991.

Authors:  A A Scitovsky; D P Rice
Journal:  Public Health Rep       Date:  1987 Jan-Feb       Impact factor: 2.792

2.  The 1987 US hospital AIDS survey.

Authors:  D P Andrulis; V B Weslowski; L S Gage
Journal:  JAMA       Date:  1989-08-11       Impact factor: 56.272

3.  Medical care costs of patients with AIDS in San Francisco.

Authors:  A A Scitovsky; M Cline; P R Lee
Journal:  JAMA       Date:  1986-12-12       Impact factor: 56.272

4.  The provision and financing of medical care for AIDS patients in US public and private teaching hospitals.

Authors:  D P Andrulis; V S Beers; J D Bentley; L S Gage
Journal:  JAMA       Date:  1987-09-11       Impact factor: 56.272

5.  Incubation period of AIDS in San Francisco.

Authors:  P Bacchetti; A R Moss
Journal:  Nature       Date:  1989-03-16       Impact factor: 49.962

6.  Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City.

Authors:  R Rothenberg; M Woelfel; R Stoneburner; J Milberg; R Parker; B Truman
Journal:  N Engl J Med       Date:  1987-11-19       Impact factor: 91.245

7.  Medical care costs of AIDS in Massachusetts.

Authors:  G R Seage; S Landers; A Barry; J Groopman; G A Lamb; A M Epstein
Journal:  JAMA       Date:  1986-12-12       Impact factor: 56.272

8.  Forecasting the personal medical care costs of AIDS from 1988 through 1991.

Authors:  F J Hellinger
Journal:  Public Health Rep       Date:  1988 May-Jun       Impact factor: 2.792

Review 9.  National forecasts of the medical care costs of AIDS: 1988-1992.

Authors:  F J Hellinger
Journal:  Inquiry       Date:  1988       Impact factor: 1.730

  9 in total
  12 in total

1.  Health services needs and related costs for HIV care.

Authors:  D P Andrulis; V B Weslowski
Journal:  Pharmacoeconomics       Date:  1992-02       Impact factor: 4.981

2.  HIV infection treatment costs under Medicaid in Michigan.

Authors:  D J Solomon; A J Hogan
Journal:  Public Health Rep       Date:  1992 Jul-Aug       Impact factor: 2.792

Review 3.  Zidovudine: a review of pharmacoeconomic and quality-of-life considerations for its use in patients with human immunodeficiency virus.

Authors:  H D Langtry; K J Palmer; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-04       Impact factor: 4.981

4.  The pharmacoeconomics of HIV disease.

Authors:  L A Lynn; K A Schulman; J M Eisenberg
Journal:  Pharmacoeconomics       Date:  1992-03       Impact factor: 4.981

5.  Needle exchange programs and social policy.

Authors:  H W Clark; J M Corbett
Journal:  J Ment Health Adm       Date:  1993

6.  Health status and national health priorities.

Authors:  D P Rice
Journal:  West J Med       Date:  1991-03

Review 7.  Optimal management strategies for HIV-infected patients who present with cough or dyspnea: a cost-effective analysis.

Authors:  K A Freedberg; A N Tosteson; D J Cotton; L Goldman
Journal:  J Gen Intern Med       Date:  1992 May-Jun       Impact factor: 5.128

8.  The economic impact of musculoskeletal disorders.

Authors:  P Lee
Journal:  Qual Life Res       Date:  1994-12       Impact factor: 4.147

9.  Longitudinal patterns of California Medicaid recipients with acquired immunodeficiency syndrome.

Authors:  R Andrews; M Keyes; P Pine
Journal:  Health Care Financ Rev       Date:  1991

10.  Inpatient charges among HIV/AIDS patients in Rhode Island from 2000-2004.

Authors:  Kamil E Barbour; Anthony Fabio; Deborah N Pearlman
Journal:  BMC Health Serv Res       Date:  2009-01-07       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.